Shaanxi Kanghui Pharmaceutical Co., Ltd.

Shanghai Stock Exchange 603139.SS

Shaanxi Kanghui Pharmaceutical Co., Ltd. Return on Capital Employed (ROCE) for the year ending December 31, 2023: -2.64%

Shaanxi Kanghui Pharmaceutical Co., Ltd. Return on Capital Employed (ROCE) is -2.64% for the year ending December 31, 2023, a 33.07% change year over year. Return on capital employed assesses profitability against invested capital; higher ROCE signals efficient capital use.

Shaanxi Kanghui Pharmaceutical Co., Ltd. Return on Capital Employed (ROCE) for the year ending December 31, 2022 was -3.94%, a -236.91% change year over year.
Shaanxi Kanghui Pharmaceutical Co., Ltd. Return on Capital Employed (ROCE) for the year ending December 31, 2021 was 2.88%, a -29.46% change year over year.
Shaanxi Kanghui Pharmaceutical Co., Ltd. Return on Capital Employed (ROCE) for the year ending December 31, 2020 was 4.08%, a -26.35% change year over year.
Shaanxi Kanghui Pharmaceutical Co., Ltd. Return on Capital Employed (ROCE) for the year ending December 31, 2019 was 5.54%, a -20.50% change year over year.

Key data

Date	Return on Capital Employed (ROCE)	Interest Coverage Ratio	Debt to Equity Ratio	Return on Common Equity

Shanghai Stock Exchange: 603139.SS

Shaanxi Kanghui Pharmaceutical Co., Ltd.

CEO	Mr. Yanling Wang
IPO Date	April 21, 2017
Location	China
Headquarters	High-tech Industrial Development Zone
Employees	952
Sector	Health Care
Industries Pharmaceuticals

Description

Shaanxi Kanghui Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in China. It offers gynecological, orthopedic, dermatology, diabetes, respiratory system, urinary system, cardiovascular and cerebrovascular, gastrointestinal, hepatobiliary, and other drugs in the form of tablets, capsules, granules, mixtures, teas, plasters, ointments, liniments, lotions, and tinctures. The company is based in Xianyang, China.

Key trends

Past 5 years